Physician profile
Rory C Dunham
NPI 1255321063
$1,304.98
in general payments reported to CMS, 2019-2025
14 companies · $290 in 2025
The $290 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $232 · 2020: $21.75 · 2021: $30.64 · 2022: $277 · 2023: $244 · 2024: $209 · 2025: $290.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $743.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $743.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $402.72 | 2019-2025 | Tfn-Advance, Healix Advance Dyna+Tape Permatape Dynacord, Vapr |
| Stryker Corporation | $215.70 | 2024-2025 | Mako |
| Zimmer Biomet Holdings, INC. | $123.55 | 2023 | Tapestry |
| Orthalign INC | $113.48 | 2022 | |
| Lima USA, INC. | $69.23 | 2019 | |
| Pylant Medical | $62.45 | 2024 | |
| Bioventus LLC | $62.11 | 2022-2025 | Durolane, Exogen Ultrasound Bone Healing System |
| Vertex Pharmaceuticals Incorporated | $57.92 | 2025 | |
| Innovation Technologies INC | $50.38 | 2023-2024 | Irrisept |
| Ethicon US, LLC | $33.95 | 2025 | Stratafix, Ethicon, Vistaseal |
| Omnilife Science, INC | $32.60 | 2019 | |
| Kerecis Limited | $30.64 | 2021 | |
| Pacira Therapeutics, INC. | $26.27 | 2019 | |
| Anika Therapeutics, INC. | $23.98 | 2025 | Integrity Implant |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rory Dunham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.